These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 11857356)
1. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation. Merat R; Amara A; Lebbe C; de The H; Morel P; Saib A Int J Cancer; 2002 Feb; 97(6):791-5. PubMed ID: 11857356 [TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta. Varthakavi V; Smith RM; Deng H; Sun R; Spearman P Virology; 2002 Jun; 297(2):270-80. PubMed ID: 12083825 [TBL] [Abstract][Full Text] [Related]
3. HIV-1 Tat Interacts with a Kaposi's Sarcoma-Associated Herpesvirus Reactivation-Upregulated Antiangiogenic Long Noncoding RNA, LINC00313, and Antagonizes Its Function. Yang WS; Lin TY; Chang L; Yeh WW; Huang SC; Chen TY; Hsieh YT; Chen ST; Li WC; Pan CC; Campbell M; Yen CH; Chen YA; Chang PC J Virol; 2020 Jan; 94(3):. PubMed ID: 31723026 [TBL] [Abstract][Full Text] [Related]
4. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388 [TBL] [Abstract][Full Text] [Related]
5. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential. Wakeman BS; Izumiya Y; Speck SH J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414 [TBL] [Abstract][Full Text] [Related]
6. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125 [TBL] [Abstract][Full Text] [Related]
7. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus. Gutierrez IV; Dayton J; Harger S; Rossetto CC J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955 [TBL] [Abstract][Full Text] [Related]
8. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells. Smith CG; Kharkwal H; Wilson DW J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496 [TBL] [Abstract][Full Text] [Related]
9. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research]. Watanabe T; Fujimuro M Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis. Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660 [TBL] [Abstract][Full Text] [Related]
11. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. Ye J; Gradoville L; Daigle D; Miller G J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling. Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900 [TBL] [Abstract][Full Text] [Related]
13. Human Immunodeficiency Virus-Associated Exosomes Promote Kaposi's Sarcoma-Associated Herpesvirus Infection via the Epidermal Growth Factor Receptor. Chen L; Feng Z; Yuan G; Emerson CC; Stewart PL; Ye F; Jin G J Virol; 2020 Apr; 94(9):. PubMed ID: 32051269 [TBL] [Abstract][Full Text] [Related]
16. Lytic induction of Kaposi's sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening. Cho HJ; Yu F; Sun R; Lee D; Song MJ Arch Virol; 2008; 153(8):1517-25. PubMed ID: 18607675 [TBL] [Abstract][Full Text] [Related]
17. Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1. Wang V; Davis DA; Deleage C; Brands C; Choi HS; Haque M; Yarchoan R J Virol; 2020 Feb; 94(5):. PubMed ID: 31801863 [TBL] [Abstract][Full Text] [Related]
18. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression. Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248 [TBL] [Abstract][Full Text] [Related]
19. Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions. Whitby D; Marshall VA; Bagni RK; Miley WJ; McCloud TG; Hines-Boykin R; Goedert JJ; Conde BA; Nagashima K; Mikovits J; Dittmer DP; Newman DJ Int J Cancer; 2007 Jan; 120(2):321-8. PubMed ID: 17066452 [TBL] [Abstract][Full Text] [Related]
20. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. Miller G; Heston L; Grogan E; Gradoville L; Rigsby M; Sun R; Shedd D; Kushnaryov VM; Grossberg S; Chang Y J Virol; 1997 Jan; 71(1):314-24. PubMed ID: 8985352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]